JBT (John Bean Technologies)
Is this your company? Claim this profile
Manufacturing & Lab Equipment
Company Overview
About
JBT (John Bean Technologies) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:United States
Founded:2011
Employees:2,429
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval IDY662
FDA · #APR-D6XT7GHF · 2021-02-01
Drug Approval CT1GRQ
PMDA · #APR-MKX5R4RN · 2021-08-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-PM9E7IX7
Issued: 2020-06-03
Expires: 2025-07-11
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-EV6WSB5M
Issued: 2020-06-14
Expires: 2025-11-26
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-OZ0D6QFT
Issued: 2020-06-18
Expires: 2025-11-28
Loading CDMO intelligence...
Key facts about JBT (John Bean Technologies)
- JBT (John Bean Technologies) is headquartered in the United States.
- JBT (John Bean Technologies) was founded in 2011.
- JBT (John Bean Technologies) has 2,429 employees.
- JBT (John Bean Technologies)'s capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like JBT (John Bean Technologies)
Directory pages this company appears in, each with the full list of matching manufacturers.